Oribalt
Oribalt Group provides pharmaceutical logistics, wholesale distribution, cold chain management, repackaging, clinical trial logistics, and pharmacy retail services across Estonia, Latvia, and Lithuania, serving pharmacies, hospitals, healthcare providers, and pharmaceutical manufacturers.
- Company typePrivate
- Founded2017
- HeadquartersMarupe, Latvia
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Oribalt does
Oribalt Group is a pharmaceutical logistics and wholesale distribution company operating across the three Baltic states of Estonia, Latvia, and Lithuania, with its headquarters in Mārupe, Latvia. The company provides an integrated suite of services including pharmaceutical wholesale distribution, warehousing and transportation, cold chain logistics, hospital and public tender management, GMP-compliant repackaging and labelling, clinical trial material logistics, marketing services for own and third-party brands, and pharmacy operations comprising two physical pharmacies in Riga and the InternetAptieka online pharmacy in Latvia. Oribalt serves pharmacies, healthcare centres, hospitals, dentists, pharmaceutical manufacturers, and other wholesale companies in the Baltic region, distributing products sourced from more than 200 producers worldwide.
The company operates from three main facilities: AS Oribalt Tallinn (Estonia), SIA Oribalt Rīga (Latvia regional headquarters), and Oribalt Vilnius UAB (Lithuania, a 6,500 sq.m purpose-built logistics centre with 8,500 pallet storage capacity constructed in 2020-2021 for EUR 4.8 million). Core technology consists of the iScala ERP system validated to GMP and GDP standards, electronic temperature monitoring, validated refrigerators and thermo boxes, and specially equipped temperature-controlled vehicles. The company holds EU GDP, GSP, and GMP compliance certifications, with each subsidiary operating an independent quality assurance structure.
Oribalt's business model is B2B-led with a sales-driven go-to-market motion. Direct sales teams visit pharmacies, supermarkets, and doctors, while the company also participates in public, municipal, and hospital tenders in cooperation with pharmaceutical manufacturers. Revenue is generated from transactional wholesale distribution margins, professional services fees for logistics, tender management, and repackaging, and consumer retail sales through physical and online pharmacies. The company was established in 2017 following the acquisition of Baltic operations from Finland's Oriola Group, continuing business operations that began in the early 1990s.
Oribalt firmographics
Firmographics- Name
- Oribalt
- Legal name
- Oribalt Group
- Website
- https://oribalt.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Oribalt Group provides pharmaceutical logistics, wholesale distribution, cold chain management, repackaging, clinical trial logistics, and pharmacy retail services across Estonia, Latvia, and Lithuania, serving pharmacies, hospitals, healthcare providers, and pharmaceutical manufacturers.
- Ownership category
- akta.pro rank
Oribalt industry classification
Industry- Product category
- Pharmaceutical Distribution and Logistics
- NAICS
- Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)
- akta.pro secondary industry
- Medical, Dental & Lab Supply Marketplaces (CRAFAHAG)
Keywords
Where Oribalt is headquartered
LocationHeadquarters
- HQ city
- Marupe
- HQ country
- Latvia
- HQ region
- Europe
Offices3 records
Markets served
Oribalt business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D
Revenue model
- Pharmaceutical Wholesale Distribution: Oribalt Group companies in Tallinn, Riga, and Vilnius distribute pharmaceutical and healthcare products to pharmacies, healthcare centres, hospitals, and dentists as pharmaceutical wholesalers. They deal with products from more than 200 producers worldwide and offer services based on customer needs according to international ethical standards.
- Pharmaceutical Logistics Services: Provides warehousing, distribution, transportation, direct delivery models, cold chain logistics, direct deliveries to patients, labelling, and other pre-wholesale services adapted to customer needs across the Baltic region.
- Hospital Tender Services: Provides tender services by gathering information about announced public, municipal, and hospital tenders, participating in tenders in cooperation with pharmaceutical manufacturers, and managing supply planning, inventory control, and contractual deliveries.
- Repackaging/Labelling Services: Provides labelling of medicinal products in accordance with Good Manufacturing Practice standards and Latvian law, including pasting of manufacturer-approved labels and insertion of patient leaflets.
- Clinical Trials Logistics: Manages the entire logistic chain of clinical trial materials and medicines including cold and ambient temperature-controlled deliveries, and provides expertise in receiving, storing, and shipping comparator compounds.
- Marketing Services: Provides traded goods including food supplements, vitamins, skincare products, and gluten-free products. Sales teams visit pharmacies, supermarkets, and doctors. Also handles sales and marketing of Oribalt Group's own brands.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels4 records
Oribalt product offering
Product offeringCore offering
Oribalt is a pharmaceutical logistics and wholesale distribution company serving the Baltic states from warehouses in Tallinn (Estonia), Riga (Latvia), and Vilnius (Lithuania). The company distributes pharmaceutical and healthcare products from more than 200 producers worldwide to pharmacies, healthcare centres, hospitals, and dentists, and provides integrated services including warehousing, transportation, temperature-controlled cold chain logistics, hospital tender participation, GMP-compliant repackaging, clinical trial material logistics, and marketing services.
Product overview
Oribalt is a pharmaceutical logistics and wholesale company operating in the Baltic region (Estonia, Latvia, Lithuania). The company offers an integrated portfolio of services: Logistics (warehousing, distribution, transportation, cold chain), Wholesale (pharmaceutical distribution to pharmacies and hospitals), Tenders (hospital procurement services), Repackaging (GMP-compliant labeling), Clinical Trials (logistics for trial materials), Marketing Services (sales and trading), and Pharmacies (InternetAptieka online pharmacy and physical pharmacies in Riga). Established in 2017 after acquiring Baltic operations from Oriola Group, the company traces its heritage to the early 1990s under the Oriola name.
Differentiator
Problem solved
Functional benefit
Brands
- InternetAptieka: Leading online pharmacy in Latvia, part of Oribalt group, offering wide range of products with fair price and free fast delivery
Products and services
- Pharmaceutical Logistics Services
- Pharmaceutical Wholesale Distribution
- Hospital Tender Services
- Repackaging Services
- Clinical Trials Logistics
- Marketing Services
- Pharmacy Operations (Panpharmacy and InternetAptieka)
Quantifiable outcome
- Storage capacity doubled to 8,500 pallet places in Lithuania with new facilities
- +2 more outcomes
Companies that use Oribalt
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles3 records
Oribalt technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Oribalt partnerships and signals
Strategic signalScale indicators7 records
Recent moves7 records
Expansion highlights4 records
Oribalt competitors and assessment
Company assessmentRegional players
- Euroapotheca: Lithuanian-headquartered pharmacy retail and wholesale group operating across the Baltic states. Comparable as a regional pharmacy and pharma distribution platform intersecting with Oribalt's wholesale and InternetAptieka pharmacy businesses.
- Sopharma Trading: Bulgarian-headquartered pharmaceutical wholesaler serving Eastern and Southeastern European markets. Comparable as a regional pharma wholesaler operating in adjacent Eastern European geographies with similar product portfolios and customer types.
Direct peers
- Tamro (Phoenix Group): Pharmaceutical wholesale distributor operating across the Baltic states and other European markets as part of Phoenix Group. Directly competes with Oribalt in Estonia, Latvia, and Lithuania across wholesale, distribution, and pharmacy services.
- Magnum Medical: Estonian-based pharmaceutical and medical device wholesaler serving pharmacies, hospitals, and healthcare providers in the Baltic region. Overlaps with Oribalt on pharmaceutical wholesale distribution in Estonia and increasingly across the Baltics.
- Oriola Corporation: Former parent of Oribalt's Baltic operations, now focused on pharmaceutical distribution and retail pharmacies in Finland and Sweden. Operates the same wholesale-plus-pharmacy model and was Oribalt's structural predecessor.
Broad incumbents
- McKesson: Global pharmaceutical wholesaler and healthcare services company. Comparable to Oribalt as a wholesale/distribution peer at the category level, with substantially greater scale and geographic reach.
- BENU Apotheek: European pharmacy retail chain (part of Phoenix Group) operating across multiple European countries. Comparable to Oribalt's downstream pharmacy/retail layer (physical pharmacies and InternetAptieka).
- Cencora: Global pharmaceutical distribution and services company (formerly AmerisourceBergen). Sets the broader competitive reference point for pharmaceutical distribution scale, logistics, and manufacturer services globally.
- Phoenix Group: Pan-European pharmaceutical distribution and pharmacy retail group headquartered in Germany; parent of Tamro. Competes with Oribalt at the regional level via Tamro and represents the most direct large-scale incumbent in the Baltic wholesale market.
- Mediq: European distributor of medical devices, pharmaceuticals, and related healthcare supplies to hospitals, pharmacies, and care providers. Comparable to Oribalt on the medical/pharmaceutical supply distribution side of the business.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Oribalt social profiles
Digital presenceOribalt compliance and trust
Trust signalCompliance3 records
Oribalt financial estimates
Financial estimateRevenue estimate
Valuation estimate
Oribalt leadership team
Management profileNumber of profiles
Profiles6 records
Oribalt subsidiaries and ownership
Company hierarchySubsidiaries2 records
Oribalt funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Oribalt M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Oribalt
What does Oribalt do?
Oribalt is a pharmaceutical logistics and wholesale distribution company serving the Baltic states from warehouses in Tallinn (Estonia), Riga (Latvia), and Vilnius (Lithuania). The company distributes pharmaceutical and healthcare products from more than 200 producers worldwide to pharmacies, healthcare centres, hospitals, and dentists, and provides integrated services including warehousing, transportation, temperature-controlled cold chain logistics, hospital tender participation, GMP-compliant repackaging, clinical trial material logistics, and marketing services.
Is Oribalt a public or private company?
Oribalt is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Oribalt founded?
Oribalt was founded in 2017. It employs 51 to 100 people.
Where is Oribalt based?
Oribalt is headquartered in Marupe, Latvia, in the Europe region.
How does Oribalt make money?
Six revenue lines are on record. Pharmaceutical Wholesale Distribution is the primary driver. The others are pharmaceutical Logistics Services, hospital Tender Services, repackaging/Labelling Services, clinical Trials Logistics and marketing Services.
Who are Oribalt's main competitors?
Regional players on record are Euroapotheca and Sopharma Trading. Direct peers are Tamro (Phoenix Group), Magnum Medical and Oriola Corporation. Broad incumbents are McKesson, BENU Apotheek, Cencora, Phoenix Group and Mediq.
Does Oribalt have an API?
No public API is recorded for Oribalt.
What industry is Oribalt in?
Oribalt's product category is Pharmaceutical Distribution and Logistics. Its primary akta.pro industry code is HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply), with a secondary code of CRAFAHAG, Medical, Dental & Lab Supply Marketplaces. Its NAICS code is 423450 and its SIC code is 5047.